http://www.acc.org/Feed?clinicalTopicID=2d1edb86-1b6a-4771-8577-42769c4272ef Clinical Topic Feed: Invasive Cardiovascular Angiography and Intervention en /Latest-in-Cardiology/Articles/2026/08/10/13/07/eagles-eye-view-12aug2026 In this week’s View, Dr. Eagle looks at the wide variation in antithrombotic regimens after valve-in-valve transcatheter aortic valve replacement (TAVR). Next, he examines PARTNER-3, a 7-year study on TAVR versus surgical aortic valve replacement (SAVR) outcomes in low-risk patients. 1786537680000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/08/10/15/19/MERCURI-2 Starting dapagliflozin one day before elective cardiac surgery reduced the incidence of postoperative acute kidney injury (AKI) during the first seven days after surgery, according to results from the double-blind, placebo-controlled MERCURI-2 trial published July 30 in JAMA. 1786471800000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/08/10/15/19/FFR-in-Focus Two studies recently published in JACC: Cardiovascular Interventions provide fresh insights into coronary physiology, suggesting that angiography-derived fractional flow reserve (FFR) may be a practical alternative to wire-based FFR, while highlighting the prognostic significance of definite discordance between FFR and nonhyperemic pressure ratios (NHPR). 1786468140000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/08/03/10/06/PARTNER-3 Both TAVR and SAVR were associated with a sustained, substantial improvement in patient-reported health status among patients with severe aortic stenosis (AS) considered at low risk, according to the seven-year outcomes of the PARTNER 3 trial published July 29 in JACC. 1785862800000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/08/03/10/06/Wide-Variation-in-Antithrombotic-Regimens There is wide variation in antithrombotic regimens after valve-in-valve (ViV) TAVR and no significant differences in outcomes, according to a study published July 27 in JACC: Cardiovascular Interventions. 1785780360000 Articles and Stories /Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career! 1785581280000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/29/13/18/eagles-eye-view-29jul2026 In this week’s View, Dr. Eagle looks at a post-hoc analysis of the API-CAT trial that showed recurrent venous thromboembolism (VTE) is uncommon but associated with poor short-term survival of patients with cancer-associated thrombosis. 1785331140000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/07/27/15/09/Higher-TAVR-Volume Higher annualized TAVR volume is associated with lower complication rates but not with lower failure to rescue (FTR) rates, according to a recent study published in JACC: Cardiovascular Interventions. 1785324900000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/07/28/17/19/OPTIMA-AF Only one month of dual antithrombotic therapy followed by direct oral anticoagulant (DOAC) monotherapy proved to be noninferior in terms of efficacy and superior in terms of bleeding outcomes to the standard 12-month dual antithrombotic therapy post PCI among patients with atrial fibrillation (AFib), according to results of the OPTIMA-AF trial published July 15 in The Lancet. 1785260580000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/07/22/17/25/DAPT-MVD Extending DAPT for an additional year reduced major adverse cardiovascular events (MACE) without increasing bleeding risk compared with aspirin alone among patients with multivessel coronary artery disease (MVCAD) who had no ischemic or bleeding events one year after PCI with a drug-eluting stent, according to results of the DAPT-MVD trial published July 15 in NEJM. 1784749860000 Articles and Stories